| scholarly article | Q13442814 |
| P50 | author | Nagasuma Chandra | Q47455130 |
| P2093 | author name string | Praveen Anand | |
| P2860 | cites work | High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism | Q21131409 |
| Identification of attractive drug targets in neglected-disease pathogens using an in silico approach | Q21144522 | ||
| Open Babel: An open chemical toolbox | Q21198766 | ||
| A multi-level multi-scale approach to study essential genes in Mycobacterium tuberculosis | Q21202770 | ||
| targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis | Q21202793 | ||
| An automated method for finding molecular complexes in large protein interaction networks | Q21284295 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| TM-align: a protein structure alignment algorithm based on the TM-score | Q24522708 | ||
| Comprehensive identification of conditionally essential genes in mycobacteria | Q24555133 | ||
| The Universal Protein Resource (UniProt) | Q24558582 | ||
| Data, information, knowledge and principle: back to metabolism in KEGG | Q24568332 | ||
| DrugBank 3.0: a comprehensive resource for 'omics' research on drugs | Q24612505 | ||
| Genomic-scale prioritization of drug targets: the TDR Targets database | Q24635333 | ||
| Systems pharmacology: network analysis to identify multiscale mechanisms of drug action | Q26824166 | ||
| Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review | Q27008867 | ||
| Binding similarity network of ligand. | Q50862492 | ||
| PocketAlign a novel algorithm for aligning binding sites in protein structures. | Q51559401 | ||
| Similarity networks of protein binding sites. | Q51959646 | ||
| Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis | Q36845726 | ||
| Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis | Q37220161 | ||
| Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis | Q37460800 | ||
| Valproic acid as a promising agent to combat Alzheimer's disease | Q37596081 | ||
| The role of pemetrexed combined with targeted agents for non-small cell lung cancer | Q37617444 | ||
| Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis | Q37643668 | ||
| Systems pharmacology of adverse event mitigation by drug combinations | Q37658567 | ||
| Network approaches to drug discovery | Q38058888 | ||
| Advances in the development of new tuberculosis drugs and treatment regimens | Q38102921 | ||
| Network-based tools for the identification of novel drug targets. | Q39749340 | ||
| PROCOGNATE: a cognate ligand domain mapping for enzymes | Q42968531 | ||
| Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain | Q43283702 | ||
| TubercuList--10 years after | Q44379430 | ||
| Cofactors in fatty acid biosynthesis-active site organizers and drug targets | Q44796679 | ||
| Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. | Q45908190 | ||
| AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
| The KEGG resource for deciphering the genome | Q27860687 | ||
| AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR | Q27860778 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis | Q28469010 | ||
| The Mycobacterium tuberculosis drugome and its polypharmacological implications | Q28476004 | ||
| Structural annotation of Mycobacterium tuberculosis proteome | Q28477725 | ||
| Target prediction for an open access set of compounds active against Mycobacterium tuberculosis | Q28534065 | ||
| Pfam: the protein families database | Q28660698 | ||
| The molecular surface package | Q29039306 | ||
| BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences | Q29547807 | ||
| Statistical potential for assessment and prediction of protein structures | Q29615145 | ||
| Verification of protein structures: patterns of nonbonded atomic interactions | Q29615613 | ||
| c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571). | Q30157972 | ||
| Pocketome via comprehensive identification and classification of ligand binding envelopes. | Q30350345 | ||
| PocketDepth: a new depth based algorithm for identification of ligand binding sites in proteins. | Q30365309 | ||
| Validation of protein models by a neural network approach. | Q30367436 | ||
| EasyMIFS and SiteHound: a toolkit for the identification of ligand-binding sites in protein structures. | Q30381172 | ||
| PocketAnnotate: towards site-based function annotation. | Q30417121 | ||
| Automated design of ligands to polypharmacological profiles. | Q30539786 | ||
| LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation | Q30826242 | ||
| PocketMatch: a new algorithm to compare binding sites in protein structures | Q33394020 | ||
| Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein | Q33796184 | ||
| Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: an in vivo microiontophoretic study. | Q33887652 | ||
| Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid | Q33995482 | ||
| The rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs | Q34024913 | ||
| clusterMaker: a multi-algorithm clustering plugin for Cytoscape | Q34070756 | ||
| The CoFactor database: organic cofactors in enzyme catalysis | Q34129249 | ||
| para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis | Q34351796 | ||
| Systems approaches to polypharmacology and drug discovery | Q34746314 | ||
| Binding MOAD, a high-quality protein-ligand database. | Q36454178 | ||
| New and continuing developments at PROSITE. | Q36491615 | ||
| Detecting overlapping protein complexes in protein-protein interaction networks | Q36528169 | ||
| Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains | Q36558371 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 6356 | |
| P577 | publication date | 2014-09-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Characterizing the pocketome of Mycobacterium tuberculosis and application in rationalizing polypharmacological target selection | |
| P478 | volume | 4 |
| Q42083154 | A genome-wide structure-based survey of nucleotide binding proteins in M. tuberculosis. |
| Q46607752 | A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis. |
| Q39019116 | Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB). |
| Q37644425 | Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB. |
| Q90396097 | Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis |
| Q40475389 | Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv. |
| Q30400313 | Resolving protein structure-function-binding site relationships from a binding site similarity network perspective. |
| Q35797482 | SInCRe-structural interactome computational resource for Mycobacterium tuberculosis. |
| Q58586170 | Transcriptional Profile of in an Model of Intraocular Tuberculosis |
| Q64059475 | Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens |
| Q42700482 | Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview |
| Q57001273 | eModel-BDB: a database of comparative structure models of drug-target interactions from the Binding Database |
Search more.